Less than a year after its launch, microbiome profiling startup Jona has already given its user interface a makeover. After receiving feedback from users saying they were having some difficulty navigating the startup’s microbiome…
Continue Reading
ImpriMed, a precision medicine company, announced that it has expanded its services to include human oncology.The aim is to provide drug-response predictions for routine blood cancers such as newly diagnosed multiple myeloma and acute…
Continue Reading
GP blood testing services across south east London have been restored following the cyber attack on Synnovis, NHS London has confirmed.
The ransomware attack in June 2024 caused disruption to pathology services in Southwark, Lambeth…
What You Should Know:
– Cardinal Health (NYSE: CAH) has announced a definitive agreement to acquire Integrated Oncology Network (ION), a physician-led independent community oncology network, for $1.115 billion in cash.
– The acquisition will integrate…
Continue Reading
Leeds Teaching Hospitals NHS Trust (LTHT) is piloting an AI solution, designed by Lucida Medical, to assess whether it can improve prostate cancer diagnosis.
The one-month pilot, which began in August 2024, is testing the effectiveness…
Smaller healthcare organizations such as rural and community hospitals are seen as easy targets for bad actors due to their lack of cybersecurity resources. However, a successful ransomware attack can impact patient care, cost…
Continue Reading
The American Medical Association (AMA) has released its 2025 Current Procedural Terminology (CPT) code set, a crucial update designed to align medical coding with the latest advancements in healthcare. This year’s update includes 420…
Continue Reading
What You Should Know:
– Verily, a precision health technology company, announced a significant expansion of its wastewater surveillance program into the United Kingdom through an exclusive partnership with Bangor University.
– This collaboration will leverage the university’s…
Continue Reading
This paper reports the results of a hybrid effectiveness-implementation randomized trial that systematically varied levels of human oversight required to support the implementation of a digital medicine intervention for persons with mild-to-moderate alcohol use…
Continue Reading
What You Should Know:
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a partnership with the Agostino Gemelli University Polyclinic Foundation IRCCS (“Policlinico Gemelli”) to establish an in-house liquid biopsy testing…
Continue Reading
